| Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| GERON CORP | President and CEO, Director | Stock Option (right to buy) | 4M | Aug 7, 2025 | Direct | ||
| GLYCOMIMETICS INC | Chief Executive Officer, Director | Employee Stock Option (right to buy) | 695K | Jan 12, 2024 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
|---|---|---|---|---|---|---|---|
| GERN | GERON CORP | Aug 7, 2025 | 2 | $0 | 4 | Aug 8, 2025 | President and CEO, Director |
| GERN | GERON CORP | Aug 7, 2025 | 0 | $0 | 3 | Aug 8, 2025 | President and CEO, Director |
| GLYC | GLYCOMIMETICS INC | Jan 12, 2024 | 1 | $0 | 4 | Jan 17, 2024 | Chief Executive Officer, Director |
| GLYC | GLYCOMIMETICS INC | Jan 19, 2023 | 1 | $0 | 4 | Jan 20, 2023 | Chief Executive Officer, Director |
| GLYC | GLYCOMIMETICS INC | Nov 11, 2022 | 1 | $32.3K | 4 | Nov 14, 2022 | Chief Executive Officer, Director |
| GLYC | GLYCOMIMETICS INC | Jan 21, 2022 | 1 | $0 | 4 | Jan 25, 2022 | Chief Executive Officer, Director |
| GLYC | GLYCOMIMETICS INC | Aug 6, 2021 | 0 | $0 | 3 | Aug 10, 2021 | Chief Executive Officer, Director |